An interventional study of salpingectomy in Ovarian Cancer Prevention, sponsored by Dana Josephy. Completed at 1 site in Israel. Open to female participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2023-09-13.
Sponsored by Dana Josephy · Not applicable, Interventional, and Prevention
The goal of this study is to evaluate patient's compliance for opportunistic salpingectomy (OS) and procedure feasibility in non gynecological abdominal surgeries
Patients who are candidate for non-gynecological abdominal surgery, are offered OS. If agree, a general surgeon perform the procedure during the planned abdominal surgery
This is the only study on the registry with Dana Josephy as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Female candidates for non-gynecologic abdominal surgery
Procedure: salpingectomy
surgical removal of the fallopian tubes
patients willing for salpingectomy
The number of patients that will agree for salpingectomy
Time frame: day of enrollment
patients undergoing salpingectomy
The number of patients that will undergo salpingectomy
Time frame: from enrollment and up to 6 weeks
length of salpingectomy
the length (in minutes) of salpingectomy
Time frame: within surgery
surgical complications
complications during or after salpingectomy
Time frame: up to 30 days from surgery
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.